Showing results (451-460 of 561) with videos related to
Sort By:
Pageof 57
Practical Radiation Oncology|November 26, 2019
Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT TrialJohn L Gore, Marguerite du Plessis, Jingbin Zhang, et al.International Journal of Surgical Pathology|October 17, 2022
Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal NeoplasmsRahul Mannan, Xiaoming Wang, Pushpinder S Bawa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer SubgroupDavid P Labbé, Christopher J Sweeney, Myles Brown, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate CancerDaniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.International Journal of Radiation Oncology, Biology, Physics|January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized TrialsPaul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.European Urology Oncology|July 17, 2025
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 TrialRyan M Phillips, James A Proudfoot, Elai Davicioni, et al.European Urology|October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover TrialTodd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.Cancer|December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trialsGeorges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic DiseaseDaniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.European Urology|December 11, 2020
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate CancerKosj Yamoah, Shivanshu Awasthi, Brandon A Mahal, et al.Pageof 57